Table 3. Prediction of accelerated vBMD loss (defined as being in the upper quartile of annual % bone loss) of femoral neck and total hip by BTM in men.

vBMD loss	Model	CTX		OC		PINP
		OR	95% CI	OR	95% CI	OR	95% CI
Femoral neck
Trabecular (-12.1 to -2.6 %)	1	1.42	0.89-2.28	1.25	0.78-2.02	1.47	0.92-2.35
	2	1.43	0.88-2.32	1.25	0.76-2.05	1.44	0.89-2.34
Cortical (-6.4 to -0.3 %)	1	1.34	0.83-2.15	1.88	1.18-2.98	1.75	1.10-2.78
	2	1.29	0.79-2.10	1.84	1.13-2.99	1.68	1.04-2.72
Total hip
Trabecular (-7.7 to -1.7 %)	1	2.32	1.47-3.67	2.70	1.71-4.28	2.26	1.43-3.58
	2	2.41	1.50-3.89	2.84	1.75-4.61	2.26	1.40-3.63
Cortical (-3.4 to -0.3 %)	1	2.17	1.37-3.44	2.43	1.53-3.86	2.52	1.59-3.99
	2	2.24	1.38-3.63	2.45	1.51-3.99	2.50	1.55-4.03

Data are presented as odds ratios (95% CI) and are bold if p< 0.05 for the highest quartile of BTM levels (CTX ≥0.472, OC ≥26.94, and PINP ≥41.90) calculated by logistic regression; Model 1 - adjusted for age; Model 2 - adjusted for age, BMI, smoking, alcohol consumption, physical activity level, mobility disability, serum 25OHD, PTH, follow-up duration, DM, Oral glucocorticoid or antiepileptic drugs, and anti-bone loss drugs.